Once every two weeks, TheBodyPRO.com sends its subscribers an email newsletter highlighting some of the most noteworthy HIV/AIDS-related news and research headlines recently added to TheBodyPRO.com, as well as a selection of personal perspectives and patient-friendly materials from TheBody.com, TheBodyPRO.com's sister site geared toward the general HIV/AIDS community.
Below is an online archive of each of our email newsletters. If you'd like to sign up, just complete your free registration at TheBodyPRO.com. If you're an existing member and you'd like to modify your settings or unsubsribe from our email newsletters, please log in and modify your account information.
|Which Hepatitis C Treatment to Start in 2016|
|This Week in HIV Research: Antibody Suppresses HIV; Investigational Drug BMS-986001; and Quality of Care on Mortality|
|This Week in HIV Research: Smoking Associated With Poor HIV Outcomes; How Gay Men Decide on Condomless Sex; and More|
|High Liver Enzymes Signal Serious Disease in HIV-Positive Individuals Without Hepatitis|
|This Week in HIV Research: Tenofovir Resistance Alarmingly Common; Ongoing HIV Replication Replenishes Reservoirs; and More|
|Dolutegravir: A Powerful Drug Entering Different Research Paths|